• HC Wainwright Reaffirms "Buy" Rating for Astria Therapeutics (NASDAQ:ATXS)

    Source: Buzz FX / 28 Feb 2025 12:19:14   America/Chicago


    HC Wainwright Reaffirms "Buy" Rating for Astria Therapeutics (NASDAQ:ATXS) Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Astria Therapeutics ( NASDAQ:ATXS - Get Free Report ) 's stock had its "buy" rating restated
    Read more...
Share on,